This Article Free via Open Access: OA OA Full Text Full Text (PDF) License Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints, Permissions and Rights Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Kelberman, D. Articles by Dattani, M. T. Search for Related Content PubMed PubMed Citation Articles by Kelberman, D. Articles by Dattani, M. T.

Genetic Regulation of Pituitary Gland Development in Human and Mouse

Developmental Endocrinology Research Group (D.K., M.T.D.), Clinical and Molecular Genetics Unit, University College London Institute of Child Health, London WC1N 1EH, United Kingdom; and Divisions of Stem Cell Biology and Developmental Genetics (K.R., R.L.-B.), and Molecular Neuroendocrinology (I.C.A.F.R.), Medical Research Council National Institute for Medical Research, London NW1 2DA, United Kingdom

Correspondence: Address all correspondence and requests for reprints to: Professor Mehul T. Dattani, Developmental Endocrinology Research Group, Clinical and Molecular Genetics Unit, Institute of Child Health, 30 Guilford Street, London WC1N 1EH, United Kingdom. E-mail: m.dattani{at}ich.ucl.ac.uk.

Normal hypothalamopituitary development is closely related to that of the forebrain and is dependent upon a complex genetic cascade of transcription factors and signaling molecules that may be either intrinsic or extrinsic to the developing Rathke’s pouch. These factors dictate organ commitment, cell differentiation, and cell proliferation within the anterior pituitary. Abnormalities in these processes are associated with congenital hypopituitarism, a spectrum of disorders that includes syndromic disorders such as septo-optic dysplasia, combined pituitary hormone deficiencies, and isolated hormone deficiencies, of which the commonest is GH deficiency. The highly variable clinical phenotypes can now in part be explained due to research performed over the last 20 yr, based mainly on naturally occurring and transgenic animal models. Mutations in genes encoding both signaling molecules and transcription factors have been implicated in the etiology of hypopituitarism, with or without other syndromic features, in mice and humans. To date, mutations in known genes account for a small proportion of cases of hypopituitarism in humans. However, these mutations have led to a greater understanding of the genetic interactions that lead to normal pituitary development. This review attempts to describe the complexity of pituitary development in the rodent, with particular emphasis on those factors that, when mutated, are associated with hypopituitarism in humans.